Literature DB >> 12077079

A place for TACE.

S J H van Deventer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12077079      PMCID： PMC1773260          DOI： 10.1136/gut.51.1.5

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  12 in total

1.  The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans.

Authors:  P E Dekkers; T ten Hove; F N Lauw; H R Koene; P Lumley; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease.

Authors:  A P Sykes; R Bhogal; C Brampton; C Chander; C Whelan; M E Parsons; J Bird
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

4.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

5.  The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha receptors during human endotoxemia.

Authors:  P E Dekkers; F N Lauw; T ten Hove; A A te Velde; P Lumley; D Becherer; S J van Deventer; T van der Poll
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

6.  Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.

Authors:  L M Williams; D L Gibbons; A Gearing; R N Maini; M Feldmann; F M Brennan
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

7.  Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.

Authors:  A Lügering; M Schmidt; N Lügering; H G Pauels; W Domschke; T Kucharzik
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

8.  Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

Authors:  R B Heuschkel; T T MacDonald; G Monteleone; M Bajaj-Elliott; J A Smith; S L Pender
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

9.  Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease.

Authors:  J Brynskov; P Foegh; G Pedersen; C Ellervik; T Kirkegaard; A Bingham; T Saermark
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice.

Authors:  S Georgopoulos; D Plows; G Kollias
Journal:  J Inflamm       Date:  1996
View more
  6 in total

Review 1.  Tumor necrosis factor inhibitors for the treatment of asthma.

Authors:  Jiyoun Kim; Daniel G Remick
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

Review 2.  Biologic therapy for inflammatory bowel disease.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Therapeutic Potential of Targeting Regulated Intramembrane Proteolysis Mechanisms of Voltage-Gated Ion Channel Subunits and Cell Adhesion Molecules.

Authors:  Samantha L Hodges; Alexandra A Bouza; Lori L Isom
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

4.  Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells.

Authors:  T Kirkegaard; G Pedersen; T Saermark; J Brynskov
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

5.  Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis.

Authors:  Fang Yan; Hanwei Cao; Rupesh Chaturvedi; Uma Krishna; Stuart S Hobbs; Peter J Dempsey; Richard M Peek; Timothy L Cover; M Kay Washington; Keith T Wilson; D Brent Polk
Journal:  Gastroenterology       Date:  2009-01-01       Impact factor: 22.682

6.  Biologic targeting in the treatment of inflammatory bowel diseases.

Authors:  Matteo Bosani; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2009-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.